home / stock / inrlf / inrlf quote
Last: | $3.78 |
---|---|
Change Percent: | 0.0% |
Open: | $3.78 |
Close: | $3.78 |
High: | $3.78 |
Low: | $3.78 |
Volume: | 2,700 |
Last Trade Date Time: | 04/25/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$3.78 | $3.78 | $3.78 | $3.78 | $3.78 | 2,700 | 04-25-2024 |
$3.9 | $3.9 | $3.9 | $3.9 | $3.9 | 1,000 | 04-23-2024 |
$4.004 | $4.004 | $4.004 | $4.004 | $4.004 | 500 | 04-22-2024 |
$3.97 | $0 | $3.97 | $0 | $0 | 1 | 04-19-2024 |
$3.97 | $3.97 | $3.97 | $3.97 | $3.97 | 200 | 04-18-2024 |
$3.845 | $3.845 | $3.845 | $3.845 | $3.845 | 250 | 04-17-2024 |
$4 | $4 | $4 | $4 | $4 | 500 | 04-16-2024 |
$4.11 | $4.3 | $4.11 | $4.3 | $4.11 | 2,500 | 04-15-2024 |
$4.25 | $0 | $4.25 | $0 | $0 | 15 | 04-12-2024 |
$4.25 | $4.25 | $4.25 | $4.25 | $4.25 | 1,965 | 04-11-2024 |
$3.96 | $0 | $3.96 | $0 | $0 | 75 | 04-08-2024 |
$3.96 | $3.96 | $3.96 | $3.96 | $3.96 | 100 | 04-05-2024 |
$3.82 | $0 | $3.82 | $0 | $0 | 32 | 04-03-2024 |
$3.82 | $0 | $3.82 | $0 | $0 | 30 | 04-01-2024 |
$3.82 | $0 | $3.82 | $0 | $0 | 4 | 03-28-2024 |
$3.82 | $0 | $3.82 | $0 | $0 | 44 | 03-27-2024 |
$3.82 | $3.82 | $3.82 | $3.82 | $3.82 | 1,600 | 03-26-2024 |
$4.0515 | $4.0515 | $4.0515 | $4.0515 | $4.0515 | 499 | 03-19-2024 |
$3.81 | $3.905 | $3.81 | $3.905 | $3.81 | 1,540 | 03-18-2024 |
$3.7 | $3.7 | $3.7 | $3.7 | $3.7 | 5,000 | 03-15-2024 |
News, Short Squeeze, Breakout and More Instantly...
Valneva Se Ord Company Name:
INRLF Stock Symbol:
OTCMKTS Market:
Saint-Herblain (France), March 26, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced the initiation of a Phase 1 clinical trial to investigate the the safety and immunogenicity of VLA1601, its second-generation adjuvanted inac...
Saint-Herblain (France), March 25, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, announced today the filing, on March 22, 2024, of its 2023 Universal Registration Document (URD) with the French Financial Markets Authority (AMF) under the filing n...
Saint-Herblain (France), March 21, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced it will present on its single-shot chikungunya vaccine, IXCHIQ ® , moderate a roundtable on the Zika and chikungunya viruses, and partic...